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INTRODUCTION
The occurrence of asthma and allergies, as well as their causes, 
can be studied at many different levels such as in populations, 
individuals, organs, tissues or cells. All of these approaches are 
potentially useful, and individual researchers will focus on dif-
ferent levels of analysis depending on their training, areas of in-
terest, and availability of funding.
1
Asher and co-workers founded the International Study of 
Asthma and Allergies in Childhood (ISAAC). The ISAAC is a 
unique worldwide epidemiological research programme estab-
lished in 1991 to investigate asthma, rhinitis and eczema in 
children due to considerable concern that these conditions 
were increasing in western and developing countries, and that 
the causes of this increase were unknown.
2
ISAAC was created from a merging of two multinational col-
laborative projects each investigating variations in childhood 
asthma at the population level. These were initiative from Auck-
land, New Zealand to conduct an international comparative 
study of asthma severity, and an initiative from Bochum, Ger-
many to conduct an international study to monitor time trends 
and determinants of the prevalence of asthma and allergies in 
children.
2
By the time ISAAC was conceived, in the early 1990s, most 
previous research had looked at the reasons why some individ-
uals develop asthma and allergic conditions such as allergic 
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rhinitis and eczema. A major risk factor was a family history of 
atopic disease, but various environmental factors had been also 
considered important in the expression of disease. Such studies 
within populations had shed little light on the reasons why the 
occurrence of atopic disease varies from population to popula-
tion.
2
Factors affecting the prevalence of disease at a population lev-
el may be different to those that determine which individuals 
within a population are at greatest risk. In addition, the rela-
tionship between the three atopic conditions may be different 
among populations. It was therefore considered likely that 
“ecological” (between-population) analyses might reveal fur-
ther important determinants of asthma, allergic rhinitis and ec-
zema. There was also widespread concern that these condi-
tions were increasing in both developed and developing coun-
tries, but there was a lack of information on the burden of aller-
gic diseases in many parts of the world.
2
ISAAC Phase One was an international multi-center cross-
sectional study involving two age groups of school children, 13-
14 year olds (adolescents) and 6-7 year olds (children). Schools 
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were randomly selected from a defined geographical area. 
Written questionnaires on asthma, rhinitis and eczema symp-
toms (translated from English) were completed by the adoles-
cents at school, and at home by parents of the children. An 
asthma symptoms video questionnaire for the adolescents was 
optional.
3
ISAAC Phase Three, a repetition of Phase One after an interval 
of at least five years, examined variations in time trends of child-
hood asthma, rhinoconjunctivitis and eczema around the world, 
and expanded the world maps of these conditions. Additional 
questions on risk factors were included in an “environmental 
questionnaire” .
4 ISAAC Phase Three surveyed about 1,200,000 
children from 233 centers in 98 countries, involving almost 
800,000 children aged 13-14 years and almost 400,000 aged 6-7 
years. Of the 54 languages used in Phase Three, English was the 
most common (21%) followed by Spanish (20%), Portuguese 
(11%), Arabic (7%), Italian (6%), French (5%) and Chinese (4%). 
The number of participating centres per Region ranged from 7 
in North America to 56 in Latin America.
In more than twenty years, ISAAC involved next to two million 
children, 306 research centres in 105 countries, in 53 different 
languages, resulting in more than 500 publications, and of 
course, claimed a place in the Guinness Book of the World Re-
cords.
2
ASTHMA IN ISAAC PHASE I AND III
ISAAC Phase One used core questionnaire designed to assess 
the prevalence and severity of asthma and allergic disease in 
defined populations. In the 13-14 year age group, 155 centres 
from 56 countries participated, with a total of 463,801 children. 
The video questionnaire was completed in 99 collaborating 
centres in 42 countries, with a total of 304,796 children. For the 
6-7 years old there were 91 collaborating centres in 38 coun-
tries, with a total of 257,800 participating children.
5-7
The highest prevalence was about 20 times higher than the 
lowest prevalence (range 1.6-36.8%), with an eight-fold varia-
tion between the 10th and 90th percentiles (3.9-30.6%).
5-7 
In South America ten centres from five countries studied 
27,182 children aged 6-7 years old and 43,362 adolescents aged 
13-14 years old from fourteen centres in six countries. The core 
symptoms of asthma and rhinoconjunctivitis based on the 
12-month provided period prevalence (current prevalence) for 
6-7 and 13-14 year olds.
8 
There were significant differences in the current prevalence of 
respiratory symptoms indicative of asthma between countries 
in the region and also between centers in the same country, with 
up to twofold and fourfold variation in prevalence of current 
wheezing in children and adolescents, respectively. There was 
a trend for asthma prevalence to be lower in centers located at 
the south latitudes (Punta Arenas, Chile and Buenos Aires, Ar-
gentina) with higher rates at tropical latitudes (Lima, Peru and 
Recife and Salvador, Brazil); however, these findings were not 
always consistent. No significant difference for asthma symp-
toms was found between boys and girls.
8
The prevalence of respiratory symptoms related to asthma in 
children from South America was high and quite similar to that 
reported from industrialized countries. There was significant 
variability in the prevalence of asthma between participating 
centers, with a trend toward higher figures in centers with a trop-
ical climate. Factors known to be protective against asthma, such 
as a higher number of children per family, a higher number of 
acute viral respiratory infections and gastrointestinal parasites, 
and poor hygiene, do not seem to play a protective role in this 
region. Conversely, these factors seem to act as risk factors for 
asthma and suggest that the socioeconomic status of popula-
tions is playing a major role in the high prevalence of asthma 
symptoms.
8
Five to 10 years later the survey was repeated as ISAAC Phase 
III. For children aged 6-7 years there were 91 collaborating cen-
tres in 38 countries with a total of 257,800 participating children. 
Of centres that participated in Phase I, 106 centres in 56 coun-
tries completed the Phase III survey and met the requirements 
for analysis, with a total of 304,679 participating children in the 
13-14 year age group (overall response rate 91%); 54 centres in 
32 countries (a total of 167,513 children) also completed the 
video questionnaires in this age group. Sixty-six centres in 37 
countries, a total of 193,404 children completed the survey and 
met the requirements for analysis in the 6-7 year age group. Four 
of the centres had surveyed children aged 6-7 year: totalling 110 
centres (in either age group) in 58 countries. The mean symp-
tom prevalence of current wheeze in the last 12 months changed 
slightly from 13.2% to 13.7% in the 13-14 year age group (mean 
increase of 0.06% per year) and from 11.1% to 11.6% in the 6-7 
year age group (mean increase of 0.13% per year).
9,10 There was 
also little change in the mean symptom prevalence of severe 
asthma or the symptom prevalence with the asthma video 
questionnaire. However, the time trends in asthma symptom 
prevalence showed different regional patterns. In Western Eu-
rope, current wheeze decreased by 0.07% per year in children 
aged 13-14 years but increased by 0.20% per year in children 
aged 6-7 years. The corresponding findings per year for the oth-
er regions in children aged 13-14 years and 6-7 years, respec-
tively, were: Oceania (20.39% and 20.21%); Latin America 
(+0.32% and +0.07%); Northern and Eastern Europe (+0.26% 
and +0.05%); Africa (+0.16% and +0.10%); North America 
(+0.12% and +0.32%); Eastern Mediterranean (20.10% and 
+0.79%); Asia-Pacific (+0.07% and 20.06%); and the Indian sub-
continent (+0.02% and +0.06%). There was particularly a marked 
reduction in current asthma symptom prevalence in English 
language countries (20.51% and 20.09%). Similar patterns were 
observed for symptoms of severe asthma. However, the per-
centage of children reported to have had asthma at some time 
in their lives increased by 0.28% per year in the 13-14 year age Chong Neto et al.
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group and by 0.18% per year in the 6-7 year age group.
9,10
ISAAC Phase Three in South America was successfully con-
ducted in nine countries. There were 39 registered centers and 
all provided data for children 13-14 years old (n=118,351). There 
was not significant difference in the mean prevalence of asth-
ma symptoms between coastal and inland centers, or tropical 
and nontropical center locations. Southern latitude centers had 
significantly higher mean prevalence of current wheezing than 
northern latitude centers (Table 1).
11
Correlation between the prevalence of asthma symptoms, so-
cioeconomic status indicators (GNI and percentage of popula-
tion under the line of poverty) were only possible at country 
level. Regarding all nine South American countries, no signifi-
cant correlation was found between country-average preva-
lence of asthma symptoms and GNI and percentage of popula-
tion under the line of poverty. In Brazil, in which the proportion 
of population with African descent was officially available, no 
significant association was found between the prevalence of 
current asthma symptoms and proportion of African descent.
11
The prevalence of asthma symptoms in South American chil-
dren is high and varies largely across the region, with most cen-
ters reporting prevalence over 15%. Country average socioeco-
nomic indicators (such as GNI), tropical location, latitude, and 
altitude were unrelated to asthma symptom prevalence. The 
high prevalence of asthma symptoms found in children living 
in areas with low socioeconomic development challenges the 
protective role against asthma of low hygiene and poverty; on 
the contrary, in this region they would act as risk factors.
11
The large variability of asthma symptoms found in South 
America cannot be explained by current theories that seem fea-
sible in developed areas of the world, suggesting that complex 
ecological interactions, distinct for each place, are likely to be 
involved as main determinants for the wide variability of asth-
ma prevalence in South America.
11
RHINITIS AND ISAAC PHASE I AND III
The ISAAC protocol was also developed to verify rhinitis and 
rhinoconjunctivites epidemiology.
2-4 In the ISAAC Phase one, 
12-month prevalences of symptoms demonstrated near 30-fold 
variation in the rate of allergic-rhinoconjunctivitis symptoms 
among centres (range 1.4-39.7%), with a four-fold variation seen 
between the 10th and 90th percentiles (4.9-21%). The grouping 
of centres with a high prevalence of allergic-rhinoconjunctivitis 
symptoms into specific regions was less well defined than for 
asthma; by contrast, the centres with the lowest symptom prev-
alences of allergic rhinoconjunctivitis were similar to those of 
asthma symptoms. Several centres with the highest rhinocon-
junctivitis symptom prevalences were not represented among 
the centres with the highest asthma prevalences; therefore, the 
major risk factors for these related disorders may differ or may 
involve different latency periods and time trends.
5,7
Table 1.  Prevalence of current asthma in children and adolescents at South 
American centres
Country/Center
6-7-yr 
ISAAC I 
(%)
13-14-yr
ISAAC I 
(%)
6-7-yr 
ISAAC IIII 
(%)
13-14-yr
ISAAC III 
(%)
Argentina
Buenos Aires
8
Córdoba
2,11
Neuquén
2,11
Rosário City
2,8,11
Salta
11
15.4
-
-
17.3
-
9.9
11.2
-
11.8
-
-
-
14.9
17.9
-
-
13.6
10.2
13.4
12.5
Bolivia
Santa Cruz
11 - - - 13.5
Brazil
Aracaju
11-13
Belo Horizonte
11,12
Brasília
11,14
Caruaru
11-13
Curitiba
8,11-13,15-18
Feira de Santana
11,12
Itabira
8
Itajaí
11,12
Maceió
11-13
Manaus
11,12
Nova Iguaçu
11,12,19,20
Passo Fundo
11,12,21
Porto Alegre
8,11,12,17,18
Recife
8,11-13,17,18,22,23
Rural Santa Maria
11,12
Salvador
8,11-13,17,18
Santa Maria
11,12
Santo André
11,12
São Paulo
8,11,12,17,18,24,25
São Paulo West
8,11,12,17,18,24,25
Uberlândia
8
Vitória da Conquista
11-13
-
-
-
-
22.9
-
16.1
-
-
-
-
-
23.5
27.2
-
-
-
-
21.3
-
20.2
-
-
-
-
-
18.4
-
9.6
-
-
-
-
-
24.7
19.7
-
27
-
-
23.3
-
21.1
-
16.5
24.3
-
-
-
20.7
-
20.6
-
24.4
26.3
-
-
-
-
17.2
-
23.9
24.4
31.2
-
24.3
18.7
17.8
19.7
17.9
18.9
21.5
-
12.3
14.8
18.1
11.8
20.5
18.2
19.1
15.3
24.6
16.7
23.2
18.7
21.9
-
30.5
Chile
Calama
11
Central Santiago
2
Chiloe
11
Punta Arenas
8,11,26
South Santiago
8,11,26
Valdivia
8,11,26
-
16.5
-
17.1
16.9
20.5
-
11.7
-
6.8
11.1
11.5
-
-
17.6
21.4
14.7
11.1
16.9
13.6
17
16
Colombia
Barranquilla
2,11
Bogotá
2,11,27
Cali
2,11
-
-
-
-
-
-
15.2
10
17.3
13.8
8.5
13.8
Ecuador
Guayaquil
11
Quito
2,11
-
-
-
-
-
16.8
15.5
17.8
Paraguay
Asunción
8,11 - 19.4 - 20.9
Peru
Lima
8,11 26 - - 19.6
Uruguay
Montevideo
8,11
Paysandú
11
18
-
19
-
-
-
17.9
13.7
Venezuela
Caracas
11 - - 20 15.4
“-” represents missing data or unpublished. 
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In the Phase I, the prevalence of rhinoconjunctivitis symp-
toms in South American centres varied from 10% in Chile to 
35% in Paraguay, with three countries in the top 10 list of most 
prevalent worldwide.
5 
In Phase III of the ISAAC time trends in the prevalence of rhi-
noconjunctivitis symptoms were analysed. Cross-sectional 
questionnaire surveys with identical protocols and question-
naires were completed a mean of 7-years apart in two age groups 
comprising 498,083 children. In the 13- to 14-year age group 
106 centres in 56 countries participated, and in the 6- to 7-year 
age group 66 centres participated in 37 countries. A slight world-
wide increase in rhinoconjunctivitis prevalence was observed, 
but the variation was large among the centres and there was no 
consistent regional pattern. Prevalence increases in the older 
children exceeding 1% per year were recorded in 13 centres, in-
cluding 3 of 9 centres in Africa, 2 of 15 in Asia-Pacific, 1 of 8 in 
India, 3 of 15 in Latin America, 3 of 9 in Eastern Europe and 1 of 
34 in Western and Northern Europe. Decreasing rhinoconjunc-
tivititis prevalence of similar magnitude was only seen in four 
centres. The changes were less pronounced in the 6- to 7-year-
old children and only in one centre did any change exceed 1% 
per year. The decrease in highest prevalence rates in ISAAC 
Phase I suggests that the prevalence has peaked in those re-
gions. An increase was recorded in several centres, mostly in 
low and mid-income countries. The increases were more pro-
nounced in the older age group, suggesting that environmental 
influences on the development of allergy may not be limited to 
early childhood.
9,28,29 The prevalence of asthma in junior high 
school children increased over 5 years in Korea. However, in el-
ementary school children, the prevalence of asthma symptoms 
decreased. The reasons for the different changes in prevalence 
in different geographical regions, including Korea, remain un-
clear, although different environmental factors might be involved 
in each region at a different time justifying new studies to eval-
uate the trends over time.
30
In the Phase III of ISAAC, twenty centres involved 53,027 chil-
dren and fourty centres from nine countries evolved 118,351 
adolescents, respectively. As observed previously in ISAAC 
Phase I, the prevalence of current rhinoconjunctivitis symp-
toms among South American children in Phase III remained 
high (18.5% for the adolescents and 12.7% for the 6-7-year-old 
children) and varied widely between centers in different coun-
tries and also within a same country. These rates were among 
the highest in the world. The prevalence of current rhinocon-
junctivitis in adolescents varied 5-fold (from 8.9% in São Paulo 
West [Brazil] to 45.1% in Asuncion [Paraguay]) and 3.7-fold for 
the 6-7-year-old children (from 5.5% in Rosario City [Argentina] 
to 20.4% in Caracas [Venezuela]) (Table 2).
31
Comparing these results to those obtained in Phase I, centers 
with higher prevalence of current rhinoconjunctivitis still main-
tained it high in Phase III, and Asuncion (Paraguay) was the 
center with the highest prevalence rate in both ISAAC’s phases. 
Table 2.  Prevalence of current rhinoconjunctivitis in children and adolescents 
at South American centres
Country/Center
6-7-yr 
ISAAC I 
(%)
13-14-yr
ISAAC I 
(%)
6-7-yr 
ISAAC IIII 
(%)
13-14-yr
ISAAC III 
(%)
Argentina
Buenos Aires
2
Córdoba
2
Neuquén
28-30
Rosário City
9,28-30
Salta
9,28-30
9.9
-
-
10.5
-
21
17.4
-
24.6
-
-
-
8.9
5.5
-
-
16.9
14.8
11.3
20.9
Bolivia
Santa Cruz
9,28-30 - - - 22.4
Brazil
Aracaju
28-30,32
Belo Horizonte
28-30,32
Brasília
14,28-30,32
Caruaru
28-30,32
Curitiba
16,18,28-32
Feira de Santana
28-30
Itabira
28-31
Itajaí
28-30
Maceió
28-30
Manaus
28-30
Nova Iguaçu
28-30
Passo Fundo
21,28-30,32
Porto Alegre
2,18,28-32
Recife
2,18,28-32
Rural Santa Maria
28-30,32
Salvador
2,18,28-32
Santa Maria
28-30,32
Santo André
28-30,32
São Paulo
2,18,25,28-32
São Paulo West
28-30
Uberlândia
Vitória da Conquista
28-30
-
-
-
-
-
-
-
-
-
-
-
10.6
10.3
-
-
-
-
12.5
-
-
-
-
-
-
-
14.1
-
-
-
-
-
-
17.6
11.3
-
25
-
-
12.6
-
-
-
9.3
-
-
-
-
-
9.4
10.8
10.5
11.6
-
-
-
-
16.7
-
13.2
12
13.3
-
12.3
11.4
12.3
12.3
17
13.9
-
10.6
13.6
12.5
12.1
15.8
14.2
14.2
7.8
21.1
10
13.8
15.6
8.8
-
19.8
Chile
Calama
2,28-30
Central Santiago
2,18,28-30
Chiloe
2,28-30
Punta Arenas
2,9,28-30
South Santiago
2,9,28-30
Valdivia
2,9,28-30
-
11.2
-
8.8
11.2
8
-
15.7
-
8.4
15.7
9.8
-
-
-
11.2
13.7
11.9
22.9
-
19.1
14.1
26.3
26.3
Colombia
Barranquilla
9,28-30
Bogotá
9,28-30
Cali
9,28-30
-
-
-
-
-
-
15.4
15.6
16.7
30
22.3
23.3
Ecuador
Guayaquil
9,28-30
Quito
9,28-30
-
-
-
-
-
14.6
23.9
23.1
Paraguay
Asunción
2,9,28-30 - 34.5 - 45.1
Peru
Lima
2,9,28-30 - 19.3 - 18.7
Uruguay
Montevideo
2,9,28-30
Paysandú
9,28-30
6.6
-
16
-
-
6.7
10.6
10.2
Venezuela
Caracas
9,28-30 - - 20.4 24.9
“-” represents missing data or unpublished. 
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No correlation was observed for rhinitis symptoms prevalence 
with respect to latitude, altitude, humid/dry climate or other 
geographical aspects, suggesting that meteorological and geo-
graphic factors, individually, would not be able to explain the 
large variability of rhinitis prevalence found by both ISAAC 
phases in South America. Thus, centers located over 2,000 m al-
titude such as Bogota, Quito and Calama did not have consis-
tently higher or lower prevalence rates when compared to cen-
ters located at the sea level. The same occurred for centers with 
equatorial humid climate (as Guayaquil, Ecuador and Manaus, 
Brazil) or with cold humid climate (Chiloe, Chile), both with 
quite similar prevalence rates of current rhinoconjunctivitis 
symptoms.
31,32
Comparison of most important markers of country develop-
ment (GNP, infant mortality rate, annual proportion of regis-
tered deaths under 5 years of age due to infectious diseases, 
percentage of children younger than 1year of age immunized 
against: poliomyelitis; measles; diphtheria, tetanus, and per-
tussis; and tuberculosis, percentage of population with potable 
drinkable water service, percentage of population with sewage 
disposal services) and the prevalence of rhinitis-related symp-
toms did not show any significant correlation.
31
The ethnic differences, which might be invoked to explain the 
variability of rhinitis symptoms prevalence in South America, 
are also unlikely to be a reasonable explanation. The prevalence 
of current rhinoconjunctivitis symptoms in some locations with 
a well-known high African genetic ancestry, some cities in Bra-
zil was lower, where the most of the African South American 
ancestors live.
32 
CONCLUSION
The current prevalence of asthma and rhinoconjunctivitis in 
South America was high, different from Korea for example, 
where the prevalence was lower.
31,33 The Hygiene Hypothesis 
fail to explain the considerably higher prevalence of allergic dis-
eases in many South American countries as compared to rest of 
the world, and the difference seems to be more consistent with 
changes in environmental exposures other than hygiene. Spe-
cific environmental factors may be undoubtedly critical in ex-
plaining the different prevalence of allergic diseases but the ex-
act nature of risk factors for allergic diseases and its symptoms 
has not been fully explored.
30,31
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